• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在人类血液中存在天然抗 Tau 抗体,且在阿尔茨海默病中并未发生改变。

Naturally Occurring Antibodies to Tau Exists in Human Blood and Are Not Changed in Alzheimer's Disease.

机构信息

Department of Neurology and Clinical Center for Neuroscience, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.

Basic Medical College, Third Military Medical University (Army Medical University), Chongqing, China.

出版信息

Neurotox Res. 2020 Apr;37(4):1029-1035. doi: 10.1007/s12640-020-00161-9. Epub 2020 Feb 5.

DOI:10.1007/s12640-020-00161-9
PMID:32026360
Abstract

Hyperphosphorylated tau is an important pathological agent in Alzheimer's disease (AD). Tau effluxes from the brain to the blood could potentially stimulate the production of naturally occurring antibodies (NAbs). We aimed to investigate whether NAbs to tau (NAbs-tau) was generated in human blood and to figure out the alteration of plasma NAbs-tau level in AD patients. About 192 AD patients and 192 age-matched and non-demented controls (NC) were enrolled in the present study. Immunofluorescence staining and western blot assays were used to confirm the existence of NAbs-tau in human blood. The plasma level of NAbs-tau in NC and AD group was analyzed by ELISA. Immunofluorescence staining and western blot assays confirmed the existence of NAbs-tau in human blood. However, no significant difference in the plasma level of NAbs-tau was observed between NC and AD group. Furthermore, the plasma level of NAbs-tau had no significant correlation with MMSE scores. The present study confirmed that NAbs-tau exists in human blood but does not differ in level between the NC and AD group. Plasma NAbs-tau is not a reliable biomarker for AD.

摘要

过度磷酸化的 tau 是阿尔茨海默病 (AD) 的重要病理因子。tau 从大脑流出到血液中,可能会刺激天然存在的抗体 (NAbs) 的产生。我们旨在研究人类血液中是否产生了针对 tau 的 NAbs(NAbs-tau),并确定 AD 患者血浆 NAbs-tau 水平的变化。本研究纳入了 192 名 AD 患者和 192 名年龄匹配且无痴呆的对照组(NC)。免疫荧光染色和 Western blot 分析用于确认人类血液中 NAbs-tau 的存在。通过 ELISA 分析 NC 和 AD 组血浆 NAbs-tau 水平。免疫荧光染色和 Western blot 分析证实了人类血液中 NAbs-tau 的存在。然而,NC 和 AD 组之间的 NAbs-tau 血浆水平没有显著差异。此外,NAbs-tau 血浆水平与 MMSE 评分无显著相关性。本研究证实 NAbs-tau 存在于人类血液中,但在 NC 和 AD 组之间水平没有差异。血浆 NAbs-tau 不是 AD 的可靠生物标志物。

相似文献

1
Naturally Occurring Antibodies to Tau Exists in Human Blood and Are Not Changed in Alzheimer's Disease.在人类血液中存在天然抗 Tau 抗体,且在阿尔茨海默病中并未发生改变。
Neurotox Res. 2020 Apr;37(4):1029-1035. doi: 10.1007/s12640-020-00161-9. Epub 2020 Feb 5.
2
Circulating Naturally Occurring Antibodies to P2RY2 Are Decreased in Alzheimer's Disease.在阿尔茨海默病患者中,循环天然存在的 P2RY2 抗体减少。
J Alzheimers Dis. 2022;87(2):711-719. doi: 10.3233/JAD-215611.
3
Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.血浆淀粉样蛋白和tau 在正常衰老、轻度认知障碍和阿尔茨海默病纵向研究中的变化。
Dement Geriatr Cogn Disord. 2019;48(3-4):180-195. doi: 10.1159/000505435. Epub 2020 Jan 28.
4
Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.帕金森病痴呆患者中针对 Tau 蛋白的天然自身抗体减少。
PLoS One. 2016 Nov 1;11(11):e0164953. doi: 10.1371/journal.pone.0164953. eCollection 2016.
5
Plasma Tau Variants Detected by a Novel Anti-Tau Monoclonal Antibody: A Potential Biomarker for Alzheimer's Disease.新型抗 Tau 单克隆抗体检测到的 Tau 变体:阿尔茨海默病的潜在生物标志物。
J Alzheimers Dis. 2020;77(2):877-883. doi: 10.3233/JAD-200386.
6
A Nanoplasmonic Biosensor for Ultrasensitive Detection of Alzheimer's Disease Biomarker Using a Chaotropic Agent.一种基于纳米等离子体的生物传感器,用于使用离液剂超灵敏检测阿尔茨海默病生物标志物。
ACS Sens. 2019 Mar 22;4(3):595-602. doi: 10.1021/acssensors.8b01242. Epub 2019 Feb 22.
7
Naturally occurring autoantibodies against Aβ oligomers exhibited more beneficial effects in the treatment of mouse model of Alzheimer's disease than intravenous immunoglobulin.与静脉注射免疫球蛋白相比,天然存在的针对β淀粉样蛋白寡聚体的自身抗体在阿尔茨海默病小鼠模型的治疗中表现出更有益的效果。
Neuropharmacology. 2016 Jun;105:561-576. doi: 10.1016/j.neuropharm.2016.02.015. Epub 2016 Feb 18.
8
The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.血浆生物标志物在阿尔茨海默病早期诊断中的效能。
Int J Geriatr Psychiatry. 2014 Jul;29(7):713-9. doi: 10.1002/gps.4053. Epub 2013 Dec 7.
9
The Diagnostic Potential of Circulating Autoantibodies to Amyloid-β in Alzheimer's Disease.循环自身抗体在阿尔茨海默病中对淀粉样β的诊断潜力。
J Alzheimers Dis. 2023;94(2):537-546. doi: 10.3233/JAD-230252.
10
The Alz-tau Biomarker for Alzheimer's Disease: Study in a Caucasian Population.阿尔茨海默病的 Alz-tau 生物标志物:在白种人群中的研究。
J Alzheimers Dis. 2019;67(4):1181-1186. doi: 10.3233/JAD-180637.

引用本文的文献

1
The role of autoantibodies in Alzheimer's disease: Pathogenetic connections or epiphenomena?自身抗体在阿尔茨海默病中的作用:致病关联还是附带现象?
Alzheimers Dement. 2025 Jul;21(7):e70484. doi: 10.1002/alz.70484.
2
Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer's Disease.神经血管单元功能障碍、认知障碍和阿尔茨海默病的外周通路
Front Aging Neurosci. 2022 Apr 18;14:858429. doi: 10.3389/fnagi.2022.858429. eCollection 2022.
3
The Functional Roles and Applications of Immunoglobulins in Neurodegenerative Disease.

本文引用的文献

1
Brain Amyloid-β Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer's Disease.临床诊断为阿尔茨海默病患者的脑淀粉样蛋白-β沉积与血液生物标志物。
J Alzheimers Dis. 2019;69(1):169-178. doi: 10.3233/JAD-190056.
2
Current state of Alzheimer's fluid biomarkers.阿尔茨海默病的体液生物标志物现状。
Acta Neuropathol. 2018 Dec;136(6):821-853. doi: 10.1007/s00401-018-1932-x. Epub 2018 Nov 28.
3
Epothilone B Benefits Nigral Dopaminergic Neurons by Attenuating Microglia Activation in the 6-Hydroxydopamine Lesion Mouse Model of Parkinson's Disease.
免疫球蛋白在神经退行性疾病中的功能作用和应用。
Int J Mol Sci. 2020 Jul 26;21(15):5295. doi: 10.3390/ijms21155295.
埃坡霉素B通过减轻帕金森病6-羟基多巴胺损伤小鼠模型中的小胶质细胞激活来保护黑质多巴胺能神经元。
Front Cell Neurosci. 2018 Sep 28;12:324. doi: 10.3389/fncel.2018.00324. eCollection 2018.
4
Physiological clearance of tau in the periphery and its therapeutic potential for tauopathies.外周组织中 tau 的生理清除及其在 tau 病治疗中的潜力。
Acta Neuropathol. 2018 Oct;136(4):525-536. doi: 10.1007/s00401-018-1891-2. Epub 2018 Aug 3.
5
The ProNGF/p75NTR pathway induces tau pathology and is a therapeutic target for FTLD-tau.ProNGF/p75NTR 通路诱导 tau 病理,是 FTLD-tau 的治疗靶点。
Mol Psychiatry. 2018 Aug;23(8):1813-1824. doi: 10.1038/s41380-018-0071-z. Epub 2018 Jun 4.
6
Molecular biomarkers of Alzheimer's disease: progress and prospects.阿尔茨海默病的分子生物标志物:进展与展望。
Dis Model Mech. 2018 May 8;11(5):dmm031781. doi: 10.1242/dmm.031781.
7
Epothilone B Benefits Nigrostriatal Pathway Recovery by Promoting Microtubule Stabilization After Intracerebral Hemorrhage.表鬼臼毒素 B 通过促进脑出血后微管稳定促进黑质纹状体通路的恢复。
J Am Heart Assoc. 2018 Jan 18;7(2):e007626. doi: 10.1161/JAHA.117.007626.
8
A systemic view of Alzheimer disease - insights from amyloid-β metabolism beyond the brain.阿尔茨海默病的系统观——超越大脑的淀粉样蛋白-β代谢的新见解。
Nat Rev Neurol. 2017 Sep 29;13(10):612-623. doi: 10.1038/nrneurol.2017.111.
9
Assessment of ELISA as endpoint in neuronal cell-based assay for BoNT detection using hiPSC derived neurons.在使用人诱导多能干细胞衍生神经元进行肉毒杆菌毒素检测的基于神经元细胞的检测中,将酶联免疫吸附测定(ELISA)作为终点评估。
J Pharmacol Toxicol Methods. 2017 Nov;88(Pt 1):1-6. doi: 10.1016/j.vascn.2017.04.013. Epub 2017 Apr 29.
10
Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy.给予抗tau抗体可增加转基因小鼠和tau蛋白病患者血浆中的tau蛋白水平。
Sci Transl Med. 2017 Apr 19;9(386). doi: 10.1126/scitranslmed.aal2029.